Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
超高场定量氘 MRS 成像在人脑肿瘤应用中的发展
基本信息
- 批准号:10468203
- 负责人:
- 金额:$ 53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdultAnimal ExperimentationAnimalsAreaBasic ScienceBiochemicalBiologicalBiopsy SpecimenBrainBrain NeoplasmsCaringCell RespirationCellsCerebrumChemotherapy and/or radiationCitric Acid CycleClinicClinicalClinical TreatmentComputer softwareDataDetectionDeuteriumDevelopmentDiagnosisDiseaseEnergy MetabolismEngineeringFatality rateFunctional disorderFundingFutureGlioblastomaGlucoseGlutamatesGlutamineGlycolysisGoalsHumanHuman bodyIceImageImaging TechniquesImaging technologyImmuneIntakeInterdisciplinary StudyIntravenous infusion proceduresLabelMagnetic ResonanceMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMalignant NeoplasmsMalignant neoplasm of brainMeasurementMeasuresMetabolicMetabolic MarkerMethodsMinnesotaMitochondriaModalityModelingMonitorMutationNeurosurgeonNoiseNormal tissue morphologyOperative Surgical ProceduresOralOutcomePathologicPathologyPatientsPhysiologic pulsePilot ProjectsPositron-Emission TomographyProductionPrognosisPropertyPyruvateRF coilRadiation therapyResearchResearch PersonnelResistanceResolutionSensitivity and SpecificitySignal TransductionSiteSpecificitySpecimenTechniquesTechnologyTestingTimeTrainingUnited States National Institutes of HealthUniversitiesWarburg EffectWorkaerobic glycolysisanticancer researchbasebrain disorder diagnosisbrain morphologybrain tissuecancer cellclinical diagnosiscontrast imagingcost effectivedata analysis pipelineexpectationfluorodeoxyglucoseglucose metabolismglucose uptakehuman imagingimage processingimaging modalityimaging studyimprovedin vivoindexinginnovationkinetic modelmagnetic fieldmagnetic resonance spectroscopic imagingmetabolic imagingmetabolic rateneuro-oncologyneurochemistryneuroimagingneuropathologynovelnovel imaging techniquenovel therapeuticsoxidationquantitative imagingsoftware developmentspatiotemporalspectroscopic imagingsuccesstherapeutic developmenttooltreatment responsetumortumor heterogeneitytumor progression
项目摘要
PROJECT SUMMARY
Glioblastoma (GBM) is the most aggressive form of human cancers with very high fatality rate and short
survival time, and the cancer cells aggressively infiltrate the brain and are intrinsically resistant to
chemotherapy and radiation therapy. Intra-tumoral heterogeneity is a major challenge in therapeutic
development for GBM patients because surgical acquisition of clinical specimens cannot be used to monitor
the tumor progression and/or the underlying metabolic changes. Various neuroimaging methods have been
used to study the morphology of the brain tumors. However, the need for noninvasively characterizing the brain
tumors and their metabolic features has not been met, which should be critical for prognosis or for monitoring
the tumor progression and response to treatment. It is well known that a common hallmark of the cancer cells
is disrupted glucose metabolism, in which upregulated glycolysis is accompanied by inhibited mitochondrial
oxidation, i.e., the “Warburg effect”. Imaging the “Warburg effect” and its spatial variability in brain tumors is a
new attempt that can have a major impact on cancer research, particularly in the treatment of GBM, because
therapies aimed at reversing the Warburg effect have shown promise in GBM ; however, great efforts are
needed to develop novel metabolic imaging techniques to achieve the capabilities sought by clinicians.
We have recently initiated a project aiming to develop a neuroimaging technique based on deuterium (2H)
MRS (DMRS) detection of 2H-labeled brain metabolites following an administration of D-Glucose-6,6-d2 (d66).
Our preliminary results indicate that the dynamic DMRS imaging can determine the cerebral metabolic rates of
glucose (CMRGlc) and TCA cycle (VTCA), thus, the lactate production rate (CMRLac) in addition to the
concentrations of deuterium-labeled glucose (Glc), mixed glutamate/glutamine (Glx) and lactate (Lac) in living
brains. Furthermore, we demonstrated for the first time that the uncoupling between the glycolysis and
oxidation in brain tumor can be quantitatively imaged via mapping the [Lac]/[Glx] ratio defined as an index of
Warburg effect (IWE); and it has been shown that IWE is highly sensitive for distinguishing brain tumor from
surrounding normal tissues. In this application, we are seeking NIH funding support to move forward with the
DMRS imaging development through: i) integrated hardware and software development and the ultrahigh field
MR technology to further boost signal-to-noise ratio (SNR), spectral resolution and spatiotemporal resolution; ii)
testing the ultrahigh resolution DMRS imaging in healthy subject, and tumor patients and establishing a
quantification model and imaging processing pipeline for future application; and iii) comparing the DMRS
imaging results with the neuropathological and immunohistochemical findings of the biospecimens to
understand the correlation between the DMRSI measurements and biological features of brain tumor. Our
interdisciplinary research team with unique expertise is ready for a full-scale development of this highly
innovative and cost-effective neuroimaging essential for basic research and clinic application in neuro-oncology.
项目摘要
胶质母细胞瘤(GBM)是人类癌症中最具侵袭性的形式,具有非常高的病死率和短的发病时间。
存活时间,并且癌细胞侵袭性地浸润大脑,并且本质上抵抗癌症。
化疗和放疗。肿瘤内异质性是肿瘤治疗中的主要挑战。
GBM患者的发展,因为临床标本的手术采集不能用于监测
肿瘤进展和/或潜在的代谢变化。各种神经成像方法已经被
用来研究脑瘤的形态然而,非侵入性地描述大脑的需要
肿瘤及其代谢特征尚未得到满足,这对预后或监测至关重要
肿瘤进展和对治疗的反应。众所周知,癌细胞的一个共同特征是
是破坏葡萄糖代谢,其中上调糖酵解伴随着抑制线粒体
氧化,即,“瓦尔堡效应”。脑肿瘤中的“瓦尔堡效应”及其空间变异性成像是一种
这是一项新的尝试,可以对癌症研究产生重大影响,特别是在GBM的治疗方面,因为
旨在逆转瓦尔堡效应的疗法在GBM中显示出前景;然而,
需要开发新的代谢成像技术,以实现临床医生所寻求的能力。
我们最近启动了一个项目,旨在开发基于氘(2 H)的神经成像技术。
D-葡萄糖-6,6-d2(d 66)给药后2 H标记脑代谢物的MRS(DMRS)检测。
我们的初步结果表明,动态DMRS成像可以确定脑代谢率,
葡萄糖(CMRGlc)和TCA循环(VTCA),因此,除了乳酸产生速率(CMRLac)之外,
活体中氘标记葡萄糖(Glc)、混合谷氨酸/谷氨酰胺(Glx)和乳酸(Lac)的浓度
大脑此外,我们还首次证明了糖酵解和
脑肿瘤中的氧化可以通过绘制[Lac]/[Glx]比率来定量成像,该比率被定义为
瓦尔堡效应(IWE);并且已经表明,IWE对于区分脑肿瘤和脑胶质瘤是高度敏感的。
周围的正常组织。在这项申请中,我们正在寻求NIH的资金支持,以推进
DMRS成像开发,通过:
MR技术进一步提高信噪比(SNR)、频谱分辨率和时空分辨率; ii)
在健康受试者和肿瘤患者中测试100分辨率DMRS成像,
用于未来应用的量化模型和成像处理流水线;以及iii)比较DMRS
影像学结果与生物标本的神经病理学和免疫组化结果,
了解DMRSI测量值与脑肿瘤生物学特征之间的相关性。我们
具有独特专业知识的跨学科研究团队已准备好全面开发这一高度
是神经肿瘤学基础研究和临床应用中必不可少的创新性和低成本的神经影像学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Clark Chin-Chung Chen其他文献
Clark Chin-Chung Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Clark Chin-Chung Chen', 18)}}的其他基金
Towards intra-operative guidance in brain tumor surgery using real-time resting-state functional MRI
使用实时静息态功能 MRI 进行脑肿瘤手术的术中指导
- 批准号:
10761498 - 财政年份:2023
- 资助金额:
$ 53万 - 项目类别:
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
超高场定量氘 MRS 成像在人脑肿瘤应用中的发展
- 批准号:
10207550 - 财政年份:2019
- 资助金额:
$ 53万 - 项目类别:
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
超高场定量氘 MRS 成像在人脑肿瘤应用中的发展
- 批准号:
10686390 - 财政年份:2019
- 资助金额:
$ 53万 - 项目类别:
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma
胶质母细胞瘤获得性替莫唑胺耐药的靶向机制
- 批准号:
10057396 - 财政年份:2016
- 资助金额:
$ 53万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 53万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 53万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 53万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 53万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 53万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 53万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)